SCYNEXIS Inc (FRA:135)
€ 4.355 +0.060 (+1.4%) Market Cap: 44.69 Mil Enterprise Value: -519,000.00 PE Ratio: 0 PB Ratio: 0.77 GF Score: 40/100

SCYNEXIS Inc Corporate Update Call Transcript

Mar 31, 2026 / 12:30PM GMT
Release Date Price: €6.23 (+14.22%)
Operator

Greetings, and welcome to the SCYNEXIS 2026 corporate update call. (Operator Instructions) It is now my pleasure to introduce your host, Thomas Johnson of LifeSci Advisors. Thank you. You may begin.

Thomas Johnson
LifeSci Advisors LLC - Investor Relations

Thank you, operator. Before we begin, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning the financial outlook for the future, leadership's expectations on our clinical results, and future financial and operational performance, as well as our visit strategy. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.

Please refer to the filings with the Securities Exchange Commission, including our most recent annual report on Form 10-K and quarterly report on Form 10-Q, including each case under the caption Risk Factors, and other documents subsequently filed with and furnished to the Securities and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot